MeSH D054058 - acute coronary syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Accord Healthcare | Rivaroxaban | Rivaroxaban Accord | 2020-11-16 | |||
| AstraZeneca | Ticagrelor | Brilique | 2010-12-03 | |||
| Ticagrelor | Possia | 2010-12-03 | ||||
| Bristol Myers Squibb | Clopidogrel | Clopidogrel BMS | 2008-07-16 | |||
| Chiesi Farmaceutici | Cangrelor | Kengrexal | 2015-03-23 | |||
| Krka | Clopidogrel | Zyllt | 2009-09-28 | |||
| Mylan | Clopidogrel, Acetylsalicylic acid | Clopidogrel / Acetylsalicylic acid Mylan | 2020-01-09 | |||
| Prasugrel | Prasugrel Mylan | 2018-05-15 | ||||
| Rivaroxaban | Rivaroxaban Viatris (previously Rivaroxaban Mylan) | 2021-11-12 | ||||
| Sanofi | Clopidogrel, Acetylsalicylic acid | Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) | 2010-03-14 | |||
| Clopidogrel, Acetylsalicylic acid | DuoPlavin | 2010-03-14 | ||||
| Clopidogrel | Iscover | 1998-07-14 | ||||
| Clopidogrel | Plavix | 1998-07-15 | ||||
| Substipharm | Prasugrel | Efient | 2009-02-24 | |||
| Teva | Clopidogrel | Clopidogrel Teva (hydrogen sulphate) | 2009-07-27 | |||
| Clopidogrel | Clopidogrel ratiopharm | 2015-02-18 | ||||
| Clopidogrel, Acetylsalicylic acid | Clopidogrel/Acetylsalicylic acid Teva | 2014-09-01 | ||||
| Clopidogrel | Clopidogrel Teva Generics B.V | 2010-10-28 | ||||
| Clopidogrel | Clopidogrel Teva Pharma B.V | 2011-06-16 | ||||
| The Medicines Company | Bivalirudin | Angiox | 2004-09-20 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
69%18/26
Phase 2
73%24/33
Phase 3
61%31/51
Approved: 5Overall Success rate: 31%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use